Busan IFC Mall (2F–4F) · 6,600㎡ One-Day Comprehensive Health Screening & Specialist Care · International Patient Concierge

5.0 Verified Patient Rating

en-US

Yonsei Mirae IFC Medical Center LogoYonsei Mirae IFC Medical CenterHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesPressReviewsAbout UsContact Us

Clinic News & Media

Gangnam Severance Prof. Baik Seung Hyuk's Team Surpasses 300 Colorectal Cancer HIPEC Surgeries

Gangnam Severance Hospital Professor Baik Seung Hyuk's Team Surpasses 300 Cases of Colorectal Cancer HIPEC Surgery On the 21st, Professor Seung-Hyuk Baek's team at the Colorectal Cancer Center of...

Schedule a Consultation
Gangnam Severance Prof. Baik Seung Hyuk's Team Surpasses 300 Colorectal Cancer HIPEC Surgeries

Gangnam Severance Hospital Professor Baik Seung Hyuk's Team Surpasses 300 Cases of Colorectal Cancer HIPEC Surgery

Yonsei Mirae IFC Medical Center

On the 21st, Professor Seung-Hyuk Baek's team at the Colorectal Cancer Center of Gangnam Severance Cancer Hospital achieved 300 cases of 'Intraperitoneal Hyperthermic Chemotherapy After Tumor Reduction (HIPEC).'

Professor Paik Seung-hyuk began his HIPEC practice at Severance Hospital in July 2014 after receiving training at the Washington Cancer Institute in the United States. He later moved to Gangnam Severance Hospital, surpassed 100 cases last March, and reached 300 cases in just over a year and nine months.

HIPEC treats remaining tumors within the peritoneum by circulating 41–43 degree anticancer drugs into the abdominal cavity after surgically removing the tumors in patients with stage 4 colorectal cancer with peritoneal metastasis. It is a treatment method designed to overcome the disadvantage that conventional systemic anticancer drugs are difficult to absorb into the peritoneum. Visible tumors are surgically removed, and then anticancer drugs are administered into the abdominal cavity so that the drugs can directly penetrate the remaining microscopic tumors.

Also, HIPEC is known to be more effective than treatment at room temperature because the drug absorption rate increases and the tumor removal rate increases at temperatures of 41 to 43 degrees.

In Korea, it was approved as a new medical technology in 2013 and is used to treat peritoneal metastasis in colorectal, gastric, and ovarian cancers, but it is not yet widely utilized. This is because chemotherapy is administered during surgery, which requires more effort and time than conventional systemic chemotherapy and places a burden on more medical staff to participate.

In addition, for effective treatment, all visible tumors must be surgically removed, making the surgery highly difficult and post-operative care crucial.

Professor Baik Seung Hyuk said, “Since HIPEC is highly effective in treating conditions such as peritoneal pseudomyxoma and mesothelial tumors in addition to colorectal cancer, I will strive to bring hope to more patients.”

Reporter Yoo Dae-hyung

Yonsei Mirae IFC Medical Center

Comprehensive 6,600㎡ health screening and specialist medical center on 2F–4F of IFC Mall, 133 Jeonpo-daero, Nam-gu, Busan. Dedicated one-day checkups and specialist care for domestic and international patients.

Departments & Programs

SpecialtiesServicesMedical TeamSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksPatient ReviewsPress & Media

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© Yonsei Mirae IFC Medical Center (Business Reg. No. 320-46-00824). All rights reserved.

Clinical examination findings and treatment outcomes vary by individual health status. Please consult a board-certified specialist regarding indications and potential side effects.